389 related articles for article (PubMed ID: 27748927)
1. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
3. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
4. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
[TBL] [Abstract][Full Text] [Related]
5. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
[TBL] [Abstract][Full Text] [Related]
6. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
7. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
[TBL] [Abstract][Full Text] [Related]
8. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
[TBL] [Abstract][Full Text] [Related]
10. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
11. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
12. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
14. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
15. High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection.
Li R; Zhang H; Liu H; Lin C; Cao Y; Zhang W; Shen Z; Xu J
Oncotarget; 2016 Apr; 7(17):23909-18. PubMed ID: 26992207
[TBL] [Abstract][Full Text] [Related]
16. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
[TBL] [Abstract][Full Text] [Related]
19. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy.
Lu J; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX
Surg Oncol; 2013 Sep; 22(3):167-71. PubMed ID: 23787074
[TBL] [Abstract][Full Text] [Related]
20. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]